190 related articles for article (PubMed ID: 32945438)
1. Knockdown of Ror2 suppresses TNF‑α‑induced inflammation and apoptosis in vascular endothelial cells.
Yang X; Zhao S; Yuan H; Shi R; Gu W; Gu Z; Lu X; Zhao H
Mol Med Rep; 2020 Oct; 22(4):2981-2989. PubMed ID: 32945438
[TBL] [Abstract][Full Text] [Related]
2. Wnt5a/Ror2 pathway contributes to the regulation of cholesterol homeostasis and inflammatory response in atherosclerosis.
Zhang CJ; Zhu N; Liu Z; Shi Z; Long J; Zu XY; Tang ZW; Hu ZY; Liao DF; Qin L
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158547. PubMed ID: 31678514
[TBL] [Abstract][Full Text] [Related]
3. Wnt5a suppresses osteoblastic differentiation of human periodontal ligament stem cell-like cells via Ror2/JNK signaling.
Hasegawa D; Wada N; Yoshida S; Mitarai H; Arima M; Tomokiyo A; Hamano S; Sugii H; Maeda H
J Cell Physiol; 2018 Feb; 233(2):1752-1762. PubMed ID: 28681925
[TBL] [Abstract][Full Text] [Related]
4. WNT5A-ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3.
Arabzadeh S; Hossein G; Salehi-Dulabi Z; Zarnani AH
Cell Mol Biol Lett; 2016; 21():9. PubMed ID: 28536612
[TBL] [Abstract][Full Text] [Related]
5. Blocking Wnt5a signaling decreases CD36 expression and foam cell formation in atherosclerosis.
Ackers I; Szymanski C; Duckett KJ; Consitt LA; Silver MJ; Malgor R
Cardiovasc Pathol; 2018; 34():1-8. PubMed ID: 29474941
[TBL] [Abstract][Full Text] [Related]
6. The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells.
Yuan Y; Niu CC; Deng G; Li ZQ; Pan J; Zhao C; Yang ZL; Si WK
Int J Mol Med; 2011 Jan; 27(1):63-9. PubMed ID: 21069266
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a/Ror2 promotes vascular smooth muscle cells proliferation via activating PKC.
Shi Y; Li H; Gu J; Gong Y; Xie X; Liao D; Qin L
Folia Histochem Cytobiol; 2022; 60(3):271-279. PubMed ID: 36177743
[TBL] [Abstract][Full Text] [Related]
8. Decrease of intracellular chloride concentration promotes endothelial cell inflammation by activating nuclear factor-κB pathway.
Yang H; Huang LY; Zeng DY; Huang EW; Liang SJ; Tang YB; Su YX; Tao J; Shang F; Wu QQ; Xiong LX; Lv XF; Liu J; Guan YY; Zhou JG
Hypertension; 2012 Nov; 60(5):1287-93. PubMed ID: 23006728
[TBL] [Abstract][Full Text] [Related]
9. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
[TBL] [Abstract][Full Text] [Related]
10. Myeloma cells inhibit non-canonical wnt co-receptor ror2 expression in human bone marrow osteoprogenitor cells: effect of wnt5a/ror2 pathway activation on the osteogenic differentiation impairment induced by myeloma cells.
Bolzoni M; Donofrio G; Storti P; Guasco D; Toscani D; Lazzaretti M; Bonomini S; Agnelli L; Capocefalo A; Dalla Palma B; Neri A; Nicolini F; Lisignoli G; Russo F; Colla S; Aversa F; Giuliani N
Leukemia; 2013 Feb; 27(2):451-63. PubMed ID: 22781592
[TBL] [Abstract][Full Text] [Related]
11. The role of WNT5A and Ror2 in peritoneal membrane injury.
Padwal M; Liu L; Margetts PJ
J Cell Mol Med; 2020 Mar; 24(6):3481-3491. PubMed ID: 32052562
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis.
Maeda K; Kobayashi Y; Udagawa N; Uehara S; Ishihara A; Mizoguchi T; Kikuchi Y; Takada I; Kato S; Kani S; Nishita M; Marumo K; Martin TJ; Minami Y; Takahashi N
Nat Med; 2012 Feb; 18(3):405-12. PubMed ID: 22344299
[TBL] [Abstract][Full Text] [Related]
13. The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma.
O'Connell MP; Fiori JL; Xu M; Carter AD; Frank BP; Camilli TC; French AD; Dissanayake SK; Indig FE; Bernier M; Taub DD; Hewitt SM; Weeraratna AT
Oncogene; 2010 Jan; 29(1):34-44. PubMed ID: 19802008
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of WNT5A/ROR2 Signaling Characterizes the Progression of Barrett-Associated Esophageal Adenocarcinoma.
Lyros O; Nie L; Moore T; Medda R; Otterson M; Behmaram B; Mackinnon A; Gockel I; Shaker R; Rafiee P
Mol Cancer Res; 2016 Jul; 14(7):647-59. PubMed ID: 27084312
[TBL] [Abstract][Full Text] [Related]
15. Spinal Wnt5a Plays a Key Role in Spinal Dendritic Spine Remodeling in Neuropathic and Inflammatory Pain Models and in the Proalgesic Effects of Peripheral Wnt3a.
Simonetti M; Kuner R
J Neurosci; 2020 Aug; 40(35):6664-6677. PubMed ID: 32616667
[TBL] [Abstract][Full Text] [Related]
16. PM2.5 Induces the Expression of Inflammatory Cytokines via the Wnt5a/Ror2 Pathway in Human Bronchial Epithelial Cells.
Zou W; Wang X; Hong W; He F; Hu J; Sheng Q; Zhu T; Ran P
Int J Chron Obstruct Pulmon Dis; 2020; 15():2653-2662. PubMed ID: 33122903
[TBL] [Abstract][Full Text] [Related]
17. L-tetrahydropalamatine inhibits tumor necrosis factor-α-induced monocyte-endothelial cell adhesion through downregulation of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 involving suppression of nuclear factor-κ B signaling pathway.
Yang BR; Yu N; Deng YH; Hoi PM; Yang B; Liu GY; Cong WH; Lee SM
Chin J Integr Med; 2015 May; 21(5):361-8. PubMed ID: 25776841
[TBL] [Abstract][Full Text] [Related]
18. WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth.
Wang K; Ma F; Arai S; Wang Y; Varkaris A; Poluben L; Voznesensky O; Xie F; Zhang X; Yuan X; Balk SP
Cancer Res; 2023 Apr; 83(7):1016-1030. PubMed ID: 36622276
[TBL] [Abstract][Full Text] [Related]
19. Wnt5A regulates the expression of ROR2 tyrosine kinase receptor in ovarian cancer cells.
Hossein G; Arabzadeh S; Salehi-Dulabi Z; Dehghani-Ghobadi Z; Heidarian Y; Talebi-Juybari M
Biochem Cell Biol; 2017 Dec; 95(6):609-615. PubMed ID: 28538104
[TBL] [Abstract][Full Text] [Related]
20. Role of the Ror family receptors in Wnt5a signaling.
Kamizaki K; Minami Y; Nishita M
In Vitro Cell Dev Biol Anim; 2024 May; 60(5):489-501. PubMed ID: 38587578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
